Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
Abstract We developed a virus-like particle (VLP)-based therapeutic vaccine against angiotensin II receptor type 1, ATR-AP205-001, which could significantly reduce the blood pressure and protect target organs of hypertensive animals. In this study, we focused on the immunological effect and safety o...
Guardado en:
Autores principales: | Xiajun Hu, Yihuan Deng, Xiao Chen, Yanzhao Zhou, Hongrong Zhang, Hailang Wu, Shijun Yang, Fen Chen, Zihua Zhou, Min Wang, Zhihua Qiu, Yuhua Liao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/462bb5a5eafc4ab8b2d68050165b2407 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression
por: Zhong,Gang, et al.
Publicado: (2015) -
Acta Nº205
por: Banco Central de Chile
Publicado: (2019) -
Kinase-dead ATR differs from ATR loss by limiting the dynamic exchange of ATR and RPA
por: Demis Menolfi, et al.
Publicado: (2018) -
ATR harmony in Turkana
por: Manuela Noske
Publicado: (1996) -
Resolución 205(IX): Liberación arancelaria de los materiales de construcción = Resolution 205(IX): Tariff liberalization with respect to construction materials = Résolution 205(IX): Libération des importations de matériaux de construction
Publicado: (2014)